tiprankstipranks
Trending News
More News >
BriaCell Therapeutics Corp (TSE:BCT)
TSX:BCT
Canadian Market

BriaCell Therapeutics (BCT) Financial Statements

Compare
74 Followers

BriaCell Therapeutics Financial Overview

BriaCell Therapeutics's market cap is currently C$26.93M. The company's EPS TTM is C$-6.969; its P/E ratio is ―; BriaCell Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Sep 22Sep 21Sep 20Sep 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -20.49K$ -19.39K$ -19.44K$ -18.74K$ -18.74K
Operating Income$ -23.27M$ -15.29M$ 3.69M$ 1.38M$ 946.42K
EBITDA$ -27.22M$ -34.05M$ -17.49M$ -4.89M$ -5.74M
Net Income$ -20.30M$ -11.58M$ -2.89M$ 1.38M$ 602.68K
Balance Sheet
Cash & Short-Term Investments$ 21.25M$ 41.04M$ 57.27M$ 19.46K$ 146.71K
Total Assets$ 27.16M$ 42.58M$ 58.04M$ 478.31K$ 415.43K
Total Debt$ 0.00$ 0.00$ 25.99K$ 228.75K$ 301.33K
Net Debt$ -21.25M$ -41.04M$ -57.24M$ 209.29K$ 154.62K
Total Liabilities$ 30.94M$ 32.25M$ 782.24K$ 3.77M$ 1.06M
Stockholders' Equity$ -3.78M$ 10.33M$ 57.26M$ 0.00$ 0.00
Cash Flow
Free Cash Flow$ -23.74M$ -12.48M$ -7.75M--
Operating Cash Flow$ -23.74M$ -12.48M$ -7.75M--
Investing Cash Flow$ 0.00$ 0.00$ 0.00-$ 1.02M
Financing Cash Flow$ 3.95M$ -3.74M$ 65.00M$ 1.08M$ 2.28M
Currency in USD

BriaCell Therapeutics Earnings and Revenue History

BriaCell Therapeutics Debt to Assets

BriaCell Therapeutics Cash Flow

BriaCell Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis